209 related articles for article (PubMed ID: 23542719)
1. Essential thrombocythemia presenting as localized livedo reticularis.
Pielasinski U; Haro R; Santonja C; Kutzner H; Requena L
Am J Dermatopathol; 2013 Apr; 35(2):e22-5. PubMed ID: 23542719
[TBL] [Abstract][Full Text] [Related]
2. Clinical and histological characteristics of livedo racemosa in essential thrombocythemia: A report of two cases and review of the published works.
Inoue S; Okiyama N; Okune M; Shiraki N; Kessoku R; Fujimoto M
J Dermatol; 2017 Jan; 44(1):84-87. PubMed ID: 27570091
[TBL] [Abstract][Full Text] [Related]
3. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
[TBL] [Abstract][Full Text] [Related]
4. JAK2 mutation-negative essential thrombocythemia in a child presenting with cerebral venous thrombosis.
Khan AA; Kumar V; Anand I; Kumar M; Sharma P; Bhargava M
Hematol Oncol Stem Cell Ther; 2012; 5(1):66-8. PubMed ID: 22446615
[TBL] [Abstract][Full Text] [Related]
5. Oxalosis and livedo reticularis.
Jorquera-Barquero E; Súarez-Marrero MC; Fernández Girón F; Borrero Martín JJ
Actas Dermosifiliogr; 2013 Nov; 104(9):815-8. PubMed ID: 23103120
[TBL] [Abstract][Full Text] [Related]
6. [Neurologic complications of essential thrombocythemia. 6 cases].
Labauge R; Pagès M; Labauge P
Rev Neurol (Paris); 1991; 147(1):52-6. PubMed ID: 2014382
[TBL] [Abstract][Full Text] [Related]
7. Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: pathogenetic mechanisms and prevention.
Landolfi R; Cipriani MC; Novarese L
Best Pract Res Clin Haematol; 2006; 19(3):617-33. PubMed ID: 16781491
[TBL] [Abstract][Full Text] [Related]
8. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous manifestations in patients with essential thrombocythemia.
Itin PH; Winkelmann RK
J Am Acad Dermatol; 1991 Jan; 24(1):59-63. PubMed ID: 1999531
[TBL] [Abstract][Full Text] [Related]
10. Livedo racemosa as a marker of increased risk of recurrent thrombosis in patients with negative anti-phospholipid antibodies.
Martínez-Valle F; Ordi-Ros J; Selva-O'Callaghan A; Balada E; Solans-Laque R; Vilardell-Tarres M
Med Clin (Barc); 2009 May; 132(20):767-71. PubMed ID: 19403146
[TBL] [Abstract][Full Text] [Related]
11. [What vascular events suggest a myeloproliferative disorder?].
Hachulla E; Rose C; Trillot N; Caulier-Leleu MT; Pasturel-Michon U
J Mal Vasc; 2000 Dec; 25(5):382-387. PubMed ID: 11148402
[TBL] [Abstract][Full Text] [Related]
12. A case of essential thrombocythemia presenting with aortic thrombosis.
Oki M; Moriuchi M; Kawada H; Ogawa Y; Ando K
Tokai J Exp Clin Med; 2008 Dec; 33(4):135-7. PubMed ID: 21318983
[TBL] [Abstract][Full Text] [Related]
13. Livedo Reticularis: A Presenting Sign of Escherichia Coli Sepsis in a Newborn.
Lopes AA; Champion V; Bonacorsi S; Mitanchez D
Fetal Pediatr Pathol; 2015; 34(5):282-6. PubMed ID: 26176263
[TBL] [Abstract][Full Text] [Related]
14. [Vascular complications of essential thrombocythemia].
Bellucci S
Bull Acad Natl Med; 2007 Mar; 191(3):519-30; discussion 530-3. PubMed ID: 18072651
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and treatment of livedo reticularis on the legs].
Herrero C; Guilabert A; Mascaró-Galy JM
Actas Dermosifiliogr; 2008 Oct; 99(8):598-607. PubMed ID: 19080891
[TBL] [Abstract][Full Text] [Related]
16. Essential Thrombocythemia: The Dermatologic Point of View.
Cozzani E; Iurlo A; Merlo G; Cattaneo D; Burlando M; Pierri I; Gugliotta L; Parodi A
Clin Lymphoma Myeloma Leuk; 2015 Dec; 15(12):739-47. PubMed ID: 26432058
[TBL] [Abstract][Full Text] [Related]
17. [Very late coronary drug-eluting stent thrombosis in a patient with essential thrombocythemia: a case report of a rare association].
Mele M; Vigna C; Villella A
G Ital Cardiol (Rome); 2012; 13(7-8):520-2. PubMed ID: 22781379
[TBL] [Abstract][Full Text] [Related]
18. [Livedo reticularis by hypothermia during anesthesia for dental treatment in Down's syndrome patient].
Penna HM; Modolo NSP; Paiva DH
Braz J Anesthesiol; 2019; 69(1):78-81. PubMed ID: 29559182
[TBL] [Abstract][Full Text] [Related]
19. [Arterial thromboses and essential thrombocythemia in young patients].
Decoulx E; Millaire A; Jude B; Marquand A; Tison E; Bauters F; Ducloux G
Ann Cardiol Angeiol (Paris); 1990 Jun; 39(6):347-50. PubMed ID: 2400197
[TBL] [Abstract][Full Text] [Related]
20. Aspirin for the control of platelet activation and prevention of thrombosis in essential thrombocythemia and polycythemia vera: current insights and rationale for future studies.
Landolfi R; Di Gennaro L; Novarese L; Patrono C
Semin Thromb Hemost; 2006 Apr; 32(3):251-9. PubMed ID: 16673279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]